MX168887B - Procedimiento para la produccion de polideoxirribonucleotido defibrotide - Google Patents
Procedimiento para la produccion de polideoxirribonucleotido defibrotideInfo
- Publication number
- MX168887B MX168887B MX006108A MX610887A MX168887B MX 168887 B MX168887 B MX 168887B MX 006108 A MX006108 A MX 006108A MX 610887 A MX610887 A MX 610887A MX 168887 B MX168887 B MX 168887B
- Authority
- MX
- Mexico
- Prior art keywords
- solution
- polydeoxyribonucleotide
- until
- depolymerization
- stranded
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/17—Immunomodulatory nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a procedimiento para la producción del polideoxirribonucleótido Defibrotide, a partir de una solución de ácido nucléicos de partida, cuya solución se encuentra al menos substancialmente libre de polisacáridos y proteínas, caracterizado porque comprende las etapas de: 1) formar polideoxirribonucleótidos altamente polimerizados e interrumpidos por agregación estabilizante de los ácidos nucléicos de partida, ajustar, si es necesario, la solución a una fuerza iónica predeterminada de por lo menos 1 molar y ajustar el pH de la solución hasta alcanzarse la máxima hipercromicidad reversible; 2) despolimerizar los polideoxirribonucleótidos hasta la hipercromicidad reversible de la solución se encuentra en un valor de h igual a 15 + (-) 5, medido como un porcentaje en DNA natural, por calentamiento de la solución resultante a una temperatura de despolimerización para dicho polideoxirribonucleótido y manteniendo la solución a una temperatura de despolimerización hasta conseguirse dicho valor de hipercromicidad reversible; 3) detener entonces la reacción de despolimerización y separar los enlaces hidrógeno de cualquier fragmento de doble filamento en la solución despolimerizada, para formar fragmentos polideoxirribonucleotídicos de un solo filamento; y 4) estabilizar posteriormente los fragmentos de polideoxirribonucleótidos de un solo filamento, resultantes, por calentamiento de la solución resultante a una temperatura y a un pH mayores que los correspondientes parámetros utilizados en la reación de despolimerización, para evitar la reformación de los enlaces hidrógeno.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT20117/86A IT1190313B (it) | 1986-04-17 | 1986-04-17 | Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante |
Publications (1)
Publication Number | Publication Date |
---|---|
MX168887B true MX168887B (es) | 1993-06-14 |
Family
ID=11163944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX006108A MX168887B (es) | 1986-04-17 | 1987-04-20 | Procedimiento para la produccion de polideoxirribonucleotido defibrotide |
Country Status (20)
Country | Link |
---|---|
US (1) | US4985552A (es) |
EP (1) | EP0263155B1 (es) |
JP (1) | JP2581722B2 (es) |
KR (1) | KR880701242A (es) |
CN (1) | CN1018650B (es) |
AR (1) | AR242585A1 (es) |
AT (1) | ATE66927T1 (es) |
AU (1) | AU612976B2 (es) |
BE (1) | BE1002908A4 (es) |
CA (1) | CA1297430C (es) |
CH (1) | CH677114A5 (es) |
DE (1) | DE3772697D1 (es) |
ES (1) | ES2005168A6 (es) |
FR (1) | FR2597481B1 (es) |
GR (1) | GR870602B (es) |
IL (1) | IL82251A (es) |
IT (1) | IT1190313B (es) |
MX (1) | MX168887B (es) |
WO (1) | WO1987006235A1 (es) |
ZA (1) | ZA872755B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5182269A (en) * | 1987-09-23 | 1993-01-26 | Crinos Industria Farmacobiologica Spa | Composition for topical use having hair stimulating, anti-dandruff and anti-seborrhoic activity |
IT1252174B (it) * | 1991-12-09 | 1995-06-05 | Crinos Industria Farmaco | Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento |
IT1271685B (it) * | 1994-08-03 | 1997-06-04 | Crinos Industria Farmaco | Impiego dei polidesossiribonucleotidi nelle neuropati diabetiche |
US7026468B2 (en) | 1996-07-19 | 2006-04-11 | Valentis, Inc. | Process and equipment for plasmid purification |
US7807822B2 (en) | 1996-08-01 | 2010-10-05 | Robert Bridenbaugh | Methods for purifying nucleic acids |
ES2251134T3 (es) | 1999-06-08 | 2006-04-16 | Gentium S.P.A. | Uso de complejos entre liposomas cationicos y polidesoxirribonucleotidos como medicamentos. |
EP1147777A1 (en) | 2000-04-18 | 2001-10-24 | Crinos Industria Farmacobiologica S.p.A. | Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors |
WO2002065125A1 (en) * | 2001-02-13 | 2002-08-22 | Invitrogen Corporation | Methods and compositions for isolation of biological macromolecules |
CA2498518A1 (en) * | 2002-09-13 | 2004-03-25 | Valentis, Inc. | Apparatus and method for preparative scale purification of nucleic acids |
EP2311994A1 (en) * | 2003-08-01 | 2011-04-20 | Life Technologies Corporation | Compositions and methods for preparing short RNA molecules and other nucleic acids |
ITMI20031714A1 (it) * | 2003-09-05 | 2005-03-06 | Gentium Spa | Formazioni ad azione antitumorale. |
WO2006094917A2 (en) * | 2005-03-03 | 2006-09-14 | Gentium Spa | Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors |
EP2103689A1 (en) * | 2008-03-19 | 2009-09-23 | Gentium S.p.A. | Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
DK2637672T3 (en) | 2010-11-12 | 2018-10-22 | Gentium S R L | DEFIBROTID FOR USE IN PROPHYLAXY AND / OR TREATMENT OF GRAPHIC VERSUS HOST DISEASE (GVHD) |
US9902952B2 (en) | 2012-06-22 | 2018-02-27 | Gentrum S.R.L. | Euglobulin-based method for determining the biological activity of defibrotide |
EP3026122A1 (en) * | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Cellular-based method for determining the potency of defibrotide |
CA3071544A1 (en) | 2017-08-03 | 2019-02-07 | Jazz Pharmaceuticals Ireland Limited | Formulations comprising a nucleic acid in a high concentration |
BR112020020865A2 (pt) | 2018-04-12 | 2021-01-19 | Jazz Pharmaceuticals, Inc. | Defibrotida para prevenção e tratamento da síndrome de liberação de citocinas e neurotoxicidade associadas à imunodepleção |
WO2019213053A1 (en) | 2018-04-30 | 2019-11-07 | Gentium S.R.L. | Methods for treating patients having sinusoidal obstruction syndrome |
US20220023533A1 (en) | 2018-12-07 | 2022-01-27 | Jazz Phrmaceticals Ireland Limited | Subcutaneous delivery of high concentration formulations |
US20230190783A1 (en) | 2020-02-28 | 2023-06-22 | Jazz Pharmaceuticals Ireland Limited | Delivery of low viscosity formulations |
WO2021212055A1 (en) | 2020-04-17 | 2021-10-21 | Jazz Pharmaceuticals Ireland Limited | Defibrotide treatment for the prevention of organ rejection and injury |
TW202308659A (zh) | 2021-05-06 | 2023-03-01 | 愛爾蘭商爵士製藥愛爾蘭有限責任公司 | 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1371944A (fr) * | 1963-07-30 | 1964-09-11 | Centre Nat Rech Scient | Procédé de préparation d'acides désoxyribonucléiques hautement polymérisés |
DE2154279A1 (de) * | 1970-11-03 | 1972-05-25 | Crinos Industria Farmaco | Medikamente für das fibrinolytische System |
US3899481A (en) * | 1970-11-03 | 1975-08-12 | Crinos Industria Farmaco | Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs |
IT1043823B (it) * | 1970-11-03 | 1980-02-29 | Prephar | Procedimento per l estrazione di acidi nucleici da organi animali |
CH617963A5 (es) * | 1973-10-05 | 1980-06-30 | Derivati Organici Lab | |
SU652187A1 (ru) * | 1975-07-23 | 1979-03-15 | Киевский Ордена Ленина Государственный Университет Им. Т.Г.Шевченко | Способ получени дезоксирибонуклеиновой кислоты |
JPS554308A (en) * | 1978-06-23 | 1980-01-12 | Yuki Gosei Yakuhin Kogyo Kk | Isolation of deoxyribonucleic acid from milt of fish |
IT1170215B (it) * | 1983-09-12 | 1987-06-03 | Crinos Industria Farmaco | Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta |
IT1206341B (it) * | 1984-02-16 | 1989-04-14 | Crinos Industria Farmaco | Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio. |
-
1986
- 1986-04-17 IT IT20117/86A patent/IT1190313B/it active
-
1987
- 1987-04-10 AT AT87902502T patent/ATE66927T1/de not_active IP Right Cessation
- 1987-04-10 JP JP62502486A patent/JP2581722B2/ja not_active Expired - Fee Related
- 1987-04-10 WO PCT/EP1987/000209 patent/WO1987006235A1/en active IP Right Grant
- 1987-04-10 EP EP87902502A patent/EP0263155B1/en not_active Expired - Lifetime
- 1987-04-10 AU AU72886/87A patent/AU612976B2/en not_active Expired
- 1987-04-10 DE DE8787902502T patent/DE3772697D1/de not_active Expired - Lifetime
- 1987-04-10 KR KR1019870701176A patent/KR880701242A/ko not_active IP Right Cessation
- 1987-04-14 GR GR870602A patent/GR870602B/el unknown
- 1987-04-15 CA CA000534837A patent/CA1297430C/en not_active Expired - Lifetime
- 1987-04-15 AR AR87307312A patent/AR242585A1/es active
- 1987-04-15 ES ES8701114A patent/ES2005168A6/es not_active Expired
- 1987-04-16 CH CH1515/87A patent/CH677114A5/it not_active IP Right Cessation
- 1987-04-16 ZA ZA872755A patent/ZA872755B/xx unknown
- 1987-04-17 BE BE8700423A patent/BE1002908A4/fr not_active IP Right Cessation
- 1987-04-17 CN CN87103688A patent/CN1018650B/zh not_active Expired
- 1987-04-17 IL IL82251A patent/IL82251A/xx not_active IP Right Cessation
- 1987-04-17 FR FR878705498A patent/FR2597481B1/fr not_active Expired - Lifetime
- 1987-04-20 MX MX006108A patent/MX168887B/es unknown
-
1989
- 1989-07-05 US US07/374,561 patent/US4985552A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2005168A6 (es) | 1989-03-01 |
CN1018650B (zh) | 1992-10-14 |
GR870602B (en) | 1987-08-17 |
FR2597481B1 (fr) | 1990-01-12 |
EP0263155B1 (en) | 1991-09-04 |
CN87103688A (zh) | 1988-01-20 |
IL82251A (en) | 1991-05-12 |
AR242585A1 (es) | 1993-04-30 |
JP2581722B2 (ja) | 1997-02-12 |
JPS63503067A (ja) | 1988-11-10 |
FR2597481A1 (fr) | 1987-10-23 |
IT1190313B (it) | 1988-02-16 |
EP0263155A1 (en) | 1988-04-13 |
IL82251A0 (en) | 1987-10-30 |
KR880701242A (ko) | 1988-07-26 |
WO1987006235A1 (en) | 1987-10-22 |
DE3772697D1 (de) | 1991-10-10 |
ZA872755B (en) | 1987-10-05 |
BE1002908A4 (fr) | 1991-07-30 |
IT8620117A0 (it) | 1986-04-17 |
US4985552A (en) | 1991-01-15 |
CA1297430C (en) | 1992-03-17 |
IT8620117A1 (it) | 1987-10-17 |
ATE66927T1 (de) | 1991-09-15 |
CH677114A5 (es) | 1991-04-15 |
AU612976B2 (en) | 1991-07-25 |
AU7288687A (en) | 1987-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX168887B (es) | Procedimiento para la produccion de polideoxirribonucleotido defibrotide | |
US2426125A (en) | Manufacture of glycol alginates | |
ES2057602T3 (es) | Procedimiento para la obtencion hidrotermica de disilicato sodico cristalino. | |
KR900701808A (ko) | 알킬 글리코시드의 직접 제조방법 | |
JP2009521921A5 (es) | ||
TW349138B (en) | Novel temperature-activated polysilicic acids and their use in paper production processes | |
Melki et al. | Oscillations in microtubule polymerization: the rate of GTP regeneration on tubulin controls the period. | |
MX9703727A (es) | Preparacion de caprolactama. | |
DE3861191D1 (de) | Verfahren zur herstellung von kristalliner l-arabinose. | |
BRPI9914947B8 (pt) | processo de polimerização por aquecimento dielétrico de ácidos graxos, ésteres de ácidos graxos, hidrocarbonetos insaturados, ou derivados insaturados destes produtos e produtos assim obtidos e seus usos | |
ES2070335T3 (es) | Procedimiento para la produccion de acido hialuronico de bajo peso molecular. | |
HUP9802529A2 (hu) | Eljárás kalcium-borát előállítására | |
CN109111919A (zh) | 一种完全水溶性产物的锰离子掺杂碳量子点的制备方法 | |
GR890100070A (el) | Μέ?οδος παρασκευής Ν-φωσφονό-με?υλό-ιμινό-διοξικού οξέος. | |
BR9002842A (pt) | Processo aperfeicoado para a preparacao de acidos parafino-sul-fonicos | |
Szewczak et al. | On the conformation of the alpha sarcin stem-loop of 28S rRNA | |
EP1115654A1 (en) | Production of calcium hydrogenphosphate or monocalcium phosphate from calcium phosphate | |
SU580824A3 (ru) | Способ получени фосфата кали | |
US852371A (en) | Method of producing dicalcium phosphate. | |
SU765208A1 (ru) | Способ получени перекиси бари | |
SU1710502A1 (ru) | Способ получени гидрофосфата меди | |
SU405359A1 (ru) | Способ получени 6-диэтиленимидофосфамидо-2-диметиламино-7-метилпурина | |
SU1057502A1 (ru) | Способ получени @ , @ -диэпоксибутана | |
SU382623A1 (ru) | Способ получения 2,2-диалкил-4-арил- 5,6-бензизоиндолинов | |
Symons | Possible mechanisms for strand-breaks in DNA induced by stirring |